MedPath

A comparative study of herbal and herbo-mineral compounds in the management of Shvitra.

Phase 3
Conditions
Health Condition 1: L80- Vitiligo
Registration Number
CTRI/2022/07/043868
Lead Sponsor
ational Institute of Ayurveda Hospital Jaipur
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1) Subjects of either sex aged between 18-60 years.

2) Subjects with classical sign and symptoms of

Shvitra.

Exclusion Criteria

Known case of any other severe Skin Disorder, Chronic systemic diseases, Sexually Transmitted Diseases, Uncontrolled Diabetes Mellitus, Hypertension, any Blood Disorders or any organ failure.

Taking any other medication for the same illness.

White spots by trauma and burn.

Pregnancy and lactation.

More than 70% depigmented area are excluded.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Changes in the grade of VASI (Vitiligo Area Severity Index) score of Vitiligo <br/ ><br>Timepoint: 7 weeks
Secondary Outcome Measures
NameTimeMethod
Changes in classical sign and symptoms of Shvitra. (Vaivarnya,Suptata,Attichirouthitha,Sphutanam etc).Timepoint: 7 weeks
© Copyright 2025. All Rights Reserved by MedPath